ATXI · Avenue Therapeutics, Inc. · Exempt Offerings
$0.38
-0.05 (-10.71%)
At close · Mar 19
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Aug 7, 2026
Market Cap
$848,783
Shares
3.29M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.